Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001437749-23-023685
Filing Date
2023-08-14
Accepted
2023-08-14 16:16:03
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM 425 dffn20230814_425.htm 425 21435
2 EXHIBIT 99.1 ex_560311.htm EX-99.1 25973
3 a01.jpg GRAPHIC 3753
  Complete submission text file 0001437749-23-023685.txt   54901
Mailing Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902
Business Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filed by) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902
Business Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Subject) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-37942 | Film No.: 231170419
SIC: 2834 Pharmaceutical Preparations